Workflow
Qingdao Hi-Tech Moulds & Plastics Technology (301022)
icon
Search documents
海泰科(301022) - 国泰海通证券股份有限公司关于青岛海泰科模塑科技股份有限公司2024年度定期现场检查报告
2025-04-23 08:54
国泰海通证券股份有限公司 关于青岛海泰科模塑科技股份有限公司 2024年度定期现场检查报告 | 保荐人名称:国泰海通证券股份有限公司 | 被保荐公司简称:海泰科 | | | --- | --- | --- | | 保荐代表人姓名:尹柏元 联系电话:0755-23976996 | | | | 保荐代表人姓名:唐超 联系电话:0755-23976353 | | | | 现场检查人员姓名:尹柏元、唐超、夏瑜佳 | | | | 现场检查对应期间:2024年度 | | | | 现场检查时间:2025年2月17日-2025年2月22日、2025年3月31日、2025年4月 | | | | 14日-2025年4月15日进行现场及远程检查 | | | | 现场检查意见 一、现场检查事项 | | | | 是 否 不适用 | | | | (一)公司治理 | | | | 现场检查手段:对公司董事长(实际控制人)、高级管理人员、董事会秘书 进行访谈;查看公司主要生产经营场所情况;查阅公司章程、公司治理的相 | | | | 关规章制度;查阅公司历次董事会、监事会、股东大会会议材料。 | | | | 1.公司章程和公司治理制度是否完备、 ...
海泰科(301022) - 独立董事2024年度述职报告(张美萍)
2025-04-23 08:52
青岛海泰科模塑科技股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表: 本人(张美萍)作为青岛海泰科模塑科技股份有限公司(以下简称"公司")的第二届 董事会独立董事,根据《公司法》《上市公司独立董事管理办法》《深圳证券交易所创业板股 票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运 作》等法律法规、规范性文件以及《公司章程》《独立董事工作制度》的规定,诚实、勤勉、 独立地履行职责,积极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对相关事 项发表意见,同时充分发挥独立董事及所担任的专门委员会委员的作用,切实维护公司和股 东特别是中小股东的合法权益。现就本人 2024 年度的履职情况报告如下: 一、基本情况 (一)个人简历 张美萍女士,1980 年出生,中国国籍,硕士研究生学历,法律硕士,一级律师,无境外 永久居留权。2007 年 11 月至 2019 年 5 月,任山东德衡律师事务所副主任、合伙人;2019 年 5 月至今,任北京德和衡(青岛)律师事务所主任、高级合伙人;2019 年 8 月至今,任 公司独立董事。 (二)独立性说明 在担任公司独立董事期 ...
海泰科(301022) - 董事会对独董独立性评估的专项意见
2025-04-23 08:52
经核查独立董事丁乃秀女士、刘树国先生、张美萍女士的任职经历以及签署 的相关自查文件,上述人员未在公司担任除独立董事以外的任何职务,也未在公 司主要股东公司担任任何职务,与公司以及主要股东之间不存在利害关系或其他 可能妨碍其进行独立客观判断的关系,不存在影响独立董事独立性的情况,因此, 公司独立董事符合《上市公司独立董事管理办法》、《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》中对独立董事独立性的相关要 求。 青岛海泰科模塑科技股份有限公司董事会 青岛海泰科模塑科技股份有限公司 董事会对独立董事独立性自查情况的专项意见 根据《上市公司独立董事管理办法》、《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》的规定,青岛海泰科模塑科技股份有限 公司(以下简称"公司")第二届董事会独立董事对自身独立性情况进行了自查 并出具了《独立董事独立性自查情况表》,公司于 2025 年 4 月 23 日召开第二届 董事会第二十九次会议,审议通过了《关于独立董事独立性自查情况的专项意见 的议案》,公司董事会就独立董事丁乃秀女士、刘树国先生、张美萍女士的独立 性情况进行评估并出具 ...
海泰科(301022) - 独立董事2024年度述职报告(丁乃秀)
2025-04-23 08:52
青岛海泰科模塑科技股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表: 本人(丁乃秀)作为青岛海泰科模塑科技股份有限公司(以下简称"公司")的第二届董 事会独立董事,根据《公司法》《上市公司独立董事管理办法》《深圳证券交易所创业板股票上 市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法 律法规、规范性文件以及《公司章程》《独立董事工作制度》的规定,诚实、勤勉、独立地履 行职责,积极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对相关事项发表意见, 同时充分发挥独立董事及所担任的专门委员会委员的作用,切实维护公司和股东特别是中小 股东的合法权益。现就本人 2024 年度的履职情况报告如下: 一、基本情况 (一)个人简历 丁乃秀女士,1975 年出生,中国国籍,博士研究生学历,材料加工工程专业,青岛科技大 学教授,无境外永久居留权。2005 年 3 月至 2007 年 12 月,任青岛科技大学高分子材料教师。 2007 年 12 月至 2014 年 12 月,任青岛科技大学高分子材料副教授;2015 年 1 月至今,任青 岛科技大学高分子材料教授;201 ...
海泰科(301022) - 独立董事2024年度述职报告(刘树国)
2025-04-23 08:52
青岛海泰科模塑科技股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表: 本人(刘树国)作为青岛海泰科模塑科技股份有限公司(以下简称"公司")的第二届 董事会独立董事,根据《公司法》《上市公司独立董事管理办法》《深圳证券交易所创业板股 票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运 作》等法律法规、规范性文件以及《公司章程》《独立董事工作制度》的规定,诚实、勤勉、 独立地履行职责,积极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对相关事 项发表意见,同时充分发挥独立董事及所担任的专门委员会委员的作用,切实维护公司和股 东特别是中小股东的合法权益。现就本人 2024 年度的履职情况报告如下: 一、基本情况 (一)个人简历 刘树国先生,1979 年出生,中国国籍,本科学历,会计学专业,中国注册会计师、注册 资产评估师,无境外永久居留权。2002 年 7 月至 2005 年 3 月,任南车四方机车车辆股份有 限公司材料会计;2005 年 3 月至 2008 年 3 月,任青岛四方川崎车辆技术有限公司财务经 理;2008 年 3 月至 2015 年 7 月,历 ...
海泰科:一季度净利润同比增长5739%
news flash· 2025-04-23 08:31
海泰科(301022.SZ)发布2025年第一季度报告, 营业收入为1.92亿元,同比增长37.20%。 净利润为 1391.96万元,同比增长5738.82%。 ...
海泰科:2025一季报净利润0.14亿 同比下降0%
Tong Hua Shun Cai Bao· 2025-04-23 08:31
| 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益(元) | 0.1642 | 0.0029 | 5562.07 | 0.1065 | | 每股净资产(元) | 11.47 | 10.93 | 4.94 | 14.19 | | 每股公积金(元) | 6.96 | 6.55 | 6.26 | 8.69 | | 每股未分配利润(元) | 3.23 | 3.24 | -0.31 | 4.35 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.92 | 1.4 | 37.14 | 1.04 | | 净利润(亿元) | 0.14 | 0 | 0 | 0.09 | | 净资产收益率(%) | 1.44 | 0.02 | 7100 | 0.98 | 数据四舍五入,查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有: 2681.96万股,累计占流通股比: 51.36%,较上期变化: 39.18 万股。 一、主要 ...
海泰科(301022) - 2024 Q4 - 年度财报
2025-04-23 08:30
Financial Performance - The company's operating revenue for 2024 reached ¥678,851,952.86, representing an increase of 18.59% compared to ¥572,438,348.90 in 2023[17]. - The net profit attributable to shareholders decreased by 32.34% to ¥15,756,018.03 in 2024 from ¥23,286,753.69 in 2023[17]. - The net profit after deducting non-recurring gains and losses fell by 51.31% to ¥8,162,379.05 in 2024 from ¥16,763,649.22 in 2023[17]. - The net cash flow from operating activities improved significantly to ¥86,249,206.64 in 2024, a 301.16% increase from -¥42,876,432.64 in 2023[17]. - The total assets at the end of 2024 were ¥1,921,788,603.80, reflecting a 3.86% increase from ¥1,850,347,745.42 at the end of 2023[17]. - The net assets attributable to shareholders increased by 3.80% to ¥1,044,372,336.21 in 2024 from ¥1,006,099,194.22 in 2023[17]. - The company reported a significant decline in basic earnings per share, which fell by 32.87% to ¥0.1879 in 2024 from ¥0.2799 in 2023[17]. - The company achieved a research and development investment of 28.33 million yuan in 2024, accounting for 4.17% of its revenue[74]. - The company reported a net profit attributable to shareholders of 1,575.60 million yuan in 2024, a decrease of 32.34% compared to the previous year[84]. - The company reported a total revenue of approximately 591.43 million for its injection mold business, with a net profit of around 22.34 million[142]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 3.00 RMB per 10 shares to all shareholders based on a total share capital of 84,757,008 shares as of December 31, 2024[4]. - The company implemented a cash dividend plan for 2023, distributing 21.63 million yuan to shareholders, which accounts for 92.89% of the 2023 net profit of 23.29 million yuan[91]. - The total shares held by the board members at the end of the reporting period increased to 43,383 shares, reflecting a change due to stock incentives[182]. - The company held a temporary shareholders' meeting on January 11, 2024, with a participation rate of 63.24%, approving several amendments to the company's articles of association and rules[180]. - The annual shareholders' meeting on May 16, 2024, had a participation rate of 62.50%, where the 2023 annual report and financial statements were approved[180]. Market and Industry Trends - In 2024, China's automotive production and sales reached 31.28 million and 31.44 million units, respectively, representing year-on-year growth of 3.7% and 4.5%[29]. - Passenger vehicle production and sales were 27.48 million and 27.56 million units, with year-on-year increases of 5.2% and 5.8%[29]. - New energy vehicle sales surpassed 10 million units for the first time, accounting for over 40% of total sales, marking a new phase of high-quality development[29]. - The automotive injection mold market in China has exceeded 50 billion RMB, with expectations for continued rapid growth in the coming years[36]. - The automotive injection mold industry is benefiting from the push for lightweight vehicles, with a projected 40% reduction in vehicle weight by 2030 compared to 2015[37]. - The demand for high-quality, low-cost, and rapid production in the automotive sector is driving the injection mold industry towards larger, more complex, and economical solutions[40]. - The automotive industry's shift towards personalization and high-end features is increasing the demand for diverse interior and exterior components, impacting mold requirements[68]. Research and Development - The company has obtained 26 invention patents and 72 utility model patents, showcasing its strong innovation capabilities in injection mold technology[74]. - The company focuses on product and technology innovation, with a robust R&D management system and collaboration with academic institutions to enhance innovation capabilities[66]. - The company is actively pursuing technological advancements in injection molding to enhance product offerings and operational efficiency[102]. - The company has completed multiple projects related to injection molding technology, with products now available in the automotive parts market, enhancing its core competitiveness[104]. - R&D personnel increased from 156 in 2023 to 164 in 2024, representing a growth of 5.13%[105]. Customer Base and Sales - The company has formed a large and stable customer base, supplying molds to renowned automotive interior and exterior parts companies such as Yanfeng, IAC, and Magna[45]. - The company has established a strong customer base, supplying molds to renowned automotive brands such as General Motors, Volkswagen, and BMW[51]. - The company sold 654 sets of automotive molds in 2024, a 33.74% increase from 489 sets in 2023, attributed to improved inventory turnover[95]. - New orders for injection molds reached 852 million yuan, a year-on-year increase of 26.97%, with total orders on hand amounting to 938 million yuan, up 22.57%[84]. Financial Management and Investments - The company has established a comprehensive supplier management system, ensuring stable relationships with key suppliers for raw material procurement[61]. - The company has implemented a refined management strategy to enhance efficiency, including upgrades to the standard parts library and the launch of a knowledge management platform to improve organizational capabilities[89]. - The company has established a foreign exchange management system to control trading risks associated with foreign exchange hedging[121]. - The company has approved the use of idle raised funds for operational activities, ensuring that the fundraising plan is implemented normally[134]. - The company has not engaged in speculative derivative investments during the reporting period[122]. Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring the protection of shareholder interests[165]. - The board of directors consists of 7 members, including 3 independent directors, meeting legal requirements for composition[167]. - The company maintains complete independence in assets, personnel, finance, and operations from its controlling shareholders, ensuring no interference in decision-making[174]. - The company has implemented strict compliance with relevant laws and regulations during the review of significant proposals[200]. - The company actively promotes investor relations and ensures timely and accurate information disclosure to all shareholders[172].
海泰科(301022) - 2025 Q1 - 季度财报
2025-04-23 08:30
Financial Performance - The company's revenue for Q1 2025 reached ¥192,373,169.29, representing a 37.20% increase compared to ¥140,218,322.92 in the same period last year[5] - Net profit attributable to shareholders surged to ¥13,919,563.22, a remarkable increase of 5,738.82% from ¥238,396.91 in the previous year[5] - The net profit excluding non-recurring gains and losses was ¥12,553,880.12, up 652.95% from a loss of ¥2,270,347.09 in the same period last year[5] - Basic earnings per share rose to ¥0.1642, reflecting a staggering increase of 5,562.07% from ¥0.0029 in the same period last year[5] - Total operating revenue for the current period reached ¥192,373,169.29, a significant increase from ¥140,218,322.92 in the previous period, representing a growth of approximately 37.2%[25] - Net profit for the current period was ¥13,919,563.22, a substantial rise from ¥238,396.91 in the previous period, reflecting a growth of over 5,700%[26] - Basic and diluted earnings per share for the current period were both ¥0.1642, compared to ¥0.0029 in the previous period, marking an increase of approximately 5,572.4%[27] - The total comprehensive income for the current period was ¥14,263,426.46, compared to a loss of ¥4,213,534.94 in the previous period[27] Assets and Liabilities - The company's total assets increased by 4.72% to ¥2,012,495,393.23 from ¥1,921,788,603.80 at the end of the previous year[5] - The company's total assets as of March 31, 2025, amount to CNY 2,012,495,393.23, an increase from CNY 1,921,788,603.80 at the beginning of the period[21][23] - Current assets total CNY 1,307,109,141.17, up from CNY 1,241,500,468.98 at the start of the period[21] - The company's total liabilities are CNY 951,919,455.63, compared to CNY 877,416,267.59 at the beginning of the period[23] Cash Flow - Cash flow from operating activities showed a significant decline, with a net outflow of ¥20,445,893.41 compared to an outflow of ¥3,069,430.48 in the previous year, marking a decrease of 566.11%[5] - Net cash flow from operating activities was negative at ¥20,445,893.41, worsening from a negative cash flow of ¥3,069,430.48 in the prior period[28] - Cash flow from investing activities showed a net outflow of ¥34,753,788.90, a decline from a net inflow of ¥6,163,921.24 in the previous period[29] - Cash flow from financing activities generated a net inflow of ¥67,905,431.00, significantly higher than the previous period's inflow of ¥14,063,151.43[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,458[17] - The top 10 shareholders hold a combined 75.77% of the shares, with Sun Wenqiang holding 30.78% and Wang Jixue holding 17.39%[17] Government Support and Expenses - The company reported a 208.60% increase in tax refunds received, amounting to ¥5,992,403.10, compared to ¥1,941,808.95 in the previous year[16] - The company incurred a financial expense of -¥2,348,089.75, a decrease of 118.97% from ¥12,377,197.12 in the previous year, primarily due to foreign exchange gains[13] - The company received government subsidies amounting to ¥1,024,432.75, which is a 153.90% increase from ¥403,478.11 in the previous year[13] - The company reported a tax expense of ¥-12,891.84, a decrease from a tax expense of ¥-2,119,115.36 in the prior period[26] Investment Plans - The company plans to invest CNY 40 million in its wholly-owned subsidiary in Thailand as part of its overseas expansion strategy[19] - The company is currently undergoing the approval process for its overseas investment with relevant domestic authorities[19] Inventory and Cash Balance - The company has a cash balance of CNY 135,784,292.24, up from CNY 122,291,960.26 at the beginning of the period[21] - The inventory balance is CNY 556,448,455.89, an increase from CNY 533,621,172.09[22] - The ending cash and cash equivalents balance was ¥119,887,168.91, up from ¥117,070,895.18 at the end of the previous period[29]
海泰科(301022) - 2024年度内部控制自我评价报告
2025-04-23 08:28
青岛海泰科模塑科技股份有限公司 2024 年度内部控制自我评价报告 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管 要求(以下简称"企业内部控制规范体系"),结合青岛海泰科模塑科技股份有 限公司(以下简称"公司"或"本公司")内部控制制度和评价办法,在内部控 制日常监督和专项监督的基础上,我们对公司截至 2024 年 12 月 31 日(内部控 制评价报告基准日)的内部控制有效性进行了评价。 一、重要声明 按照企业内部控制规范体系的规定,建立健全和有效实施内部控制,评价 其有效性,并如实披露内部控制评价报告是公司董事会的责任。监事会对董事 会建立和实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运 行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在 任何虚假记载、误导性陈述或重大遗漏,并对报告内容的真实性、准确性和完 整性承担个别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告 及相关信息真实完整,提高经营效率和效果,促进实现发展战略。由于内部控 制存在的固有局限性,故仅能为实现上述目标提供合理保证。此外,由于经营 情况的变化可能 ...